185 related articles for article (PubMed ID: 30347018)
1. Association of Facility Volume With Positive Margin Rate in the Surgical Treatment of Head and Neck Cancer.
Nocon CC; Ajmani GS; Bhayani MK
JAMA Otolaryngol Head Neck Surg; 2018 Dec; 144(12):1090-1097. PubMed ID: 30347018
[TBL] [Abstract][Full Text] [Related]
2. Association of Type of Treatment Facility With Overall Survival After a Diagnosis of Head and Neck Cancer.
Carey RM; Fathy R; Shah RR; Rajasekaran K; Cannady SB; Newman JG; Ibrahim SA; Brant JA
JAMA Netw Open; 2020 Jan; 3(1):e1919697. PubMed ID: 31977060
[TBL] [Abstract][Full Text] [Related]
3. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.
Sher DJ; Nedzi L; Khan S; Hughes R; Sumer BD; Myers LL; Truelson JM; Koshy M
JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):777-88. PubMed ID: 27368076
[TBL] [Abstract][Full Text] [Related]
6. Margins in Laryngeal Squamous Cell Carcinoma Treated with Transoral Laser Microsurgery: A National Database Study.
Hanna J; Brauer PR; Morse E; Mehra S
Otolaryngol Head Neck Surg; 2019 Dec; 161(6):986-992. PubMed ID: 31476984
[TBL] [Abstract][Full Text] [Related]
7. Assessment of adjuvant therapy in resected head and neck cancer with high-risk features.
Ajmani GS; Nocon CC; Wang CH; Bhayani MK
Oral Oncol; 2017 Nov; 74():15-20. PubMed ID: 29103745
[TBL] [Abstract][Full Text] [Related]
8. Combined modality treatment outcomes for head and neck cancer: comparison of postoperative radiation therapy at academic vs nonacademic medical centers.
George JR; Yom SS; Wang SJ
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1118-26. PubMed ID: 24051518
[TBL] [Abstract][Full Text] [Related]
9. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer.
Yan F; Li H; Kaczmar JM; Sharma AK; Day TA; Neskey DM; Pipkorn P; Zenga J; Graboyes EM
JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1109-1119. PubMed ID: 32790830
[TBL] [Abstract][Full Text] [Related]
10. Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation.
Yan F; Li H; de Almeida JR; Kaczmar JM; Pipkorn P; Zenga J; Richardson MS; Neskey DM; Sharma AK; Day TA; Graboyes EM
Otolaryngol Head Neck Surg; 2021 Oct; 165(4):536-549. PubMed ID: 33618570
[TBL] [Abstract][Full Text] [Related]
11. Beyond Positive Margins and Extracapsular Extension: Evaluating the Utilization and Clinical Impact of Postoperative Chemoradiotherapy in Resected Locally Advanced Head and Neck Cancer.
Trifiletti DM; Smith A; Mitra N; Grover S; Lukens JN; Cohen RB; Read P; Mendenhall WM; Lin A; Swisher-McClure S
J Clin Oncol; 2017 May; 35(14):1550-1560. PubMed ID: 28475848
[TBL] [Abstract][Full Text] [Related]
12. Utilization and Survival of Postoperative Radiation or Chemoradiation for pT1-2N1M0 Head and Neck Cancer.
Lee A; Givi B; Roden DF; Tam MM; Wu SP; Gerber NK; Hu KS; Schreiber D
Otolaryngol Head Neck Surg; 2018 Apr; 158(4):677-684. PubMed ID: 29256329
[TBL] [Abstract][Full Text] [Related]
13. Sinonasal Squamous Cell Carcinoma Outcomes: Does Treatment at a High-Volume Center Confer Survival Benefit?
Teitelbaum JI; Issa K; Barak IR; Ackall FY; Jung SH; Jang DW; Abi Hachem R
Otolaryngol Head Neck Surg; 2020 Nov; 163(5):986-991. PubMed ID: 32600116
[TBL] [Abstract][Full Text] [Related]
14. Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database.
Murphy CT; Galloway TJ; Handorf EA; Wang L; Mehra R; Flieder DB; Ridge JA
Cancer; 2015 Apr; 121(8):1204-13. PubMed ID: 25490875
[TBL] [Abstract][Full Text] [Related]
15. Measuring Institutional Quality in Head and Neck Surgery Using Hospital-Level Data: Negative Margin Rates and Neck Dissection Yield.
Schoppy DW; Rhoads KF; Ma Y; Chen MM; Nussenbaum B; Orosco RK; Rosenthal EL; Divi V
JAMA Otolaryngol Head Neck Surg; 2017 Nov; 143(11):1111-1116. PubMed ID: 28983555
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Care in Adjuvant Therapy for Resected Oral Cavity Squamous Cell Cancer in Elderly Patients.
Pollom EL; Chin AL; Lee NY; Tsai CJ
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):758-766. PubMed ID: 28366574
[TBL] [Abstract][Full Text] [Related]
17. Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification.
Yoshida EJ; Luu M; David JM; Kim S; Mita A; Scher K; Shiao SL; Tighiouart M; Ho AS; Zumsteg ZS
Head Neck; 2018 Jun; 40(6):1228-1236. PubMed ID: 29417700
[TBL] [Abstract][Full Text] [Related]
18. Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis.
Kirke DN; Qureshi MM; Kamran SC; Ezzat W; Jalisi S; Salama A; Everett PC; Truong MT
Head Neck; 2018 Jun; 40(6):1174-1184. PubMed ID: 29417687
[TBL] [Abstract][Full Text] [Related]
19. Selection of Ideal Candidates for Surgical Salvage of Head and Neck Squamous Cell Carcinoma: Effect of the Charlson-Age Comorbidity Index and Oncologic Characteristics on 1-Year Survival and Hospital Course.
Kim J; Kim S; Albergotti WG; Choi PA; Kaplan DJ; Abberbock S; Johnson JT; Gildener-Leapman N
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1059-65. PubMed ID: 26447790
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of head and neck squamous cell carcinoma patients with N3 neck disease treated primarily with chemoradiation versus surgical resection.
Smyth JK; Deal AM; Huang B; Weissler M; Zanation A; Shores C
Laryngoscope; 2011 Sep; 121(9):1881-7. PubMed ID: 21997727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]